Literature DB >> 18199424

Caged agonist of P2Y1 and P2Y12 receptors for light-directed facilitation of platelet aggregation.

Zhan-Guo Gao1, Béatrice Hechler, Pedro Besada, Christian Gachet, Kenneth A Jacobson.   

Abstract

We have prepared a caged form (MRS2703) of a potent dual agonist of the P2Y(1) and P2Y(12) nucleotide receptors, 2-MeSADP, by blocking the beta-phosphate group with a 1-(3,4-dimethyloxyphenyl)eth-1-yl phosphoester. Although MRS2703 is itself inactive at human P2Y(1) and P2Y(12) receptors expressed heterologously in 1321N1 astrocytoma cells or in washed human platelets, this derivative readily regenerates the parent agonist upon mild irradiation with long-wave UV light (360 nm). The functional effect of the regenerated agonist was demonstrated by a rise in intracellular calcium mediated by either P2Y(1) or P2Y(12) receptors in transfected cells. Washed human platelets exposed to a solution of MRS2703 were induced to aggregate upon UV irradiation. At 1.0 microM MRS2703, full aggregation was achieved within 1 min of irradiation. Thus, this caged nucleotide promises to be a useful probe for potent P2Y receptor activation with light-directed spatial and temporal control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18199424      PMCID: PMC2367217          DOI: 10.1016/j.bcp.2007.10.037

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  22 in total

1.  (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets.

Authors:  D M Bourdon; S K Mahanty; K A Jacobson; J L Boyer; T K Harden
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

2.  Rapid photolytic release of adenosine 5'-triphosphate from a protected analogue: utilization by the Na:K pump of human red blood cell ghosts.

Authors:  J H Kaplan; B Forbush; J F Hoffman
Journal:  Biochemistry       Date:  1978-05-16       Impact factor: 3.162

Review 3.  Regulation of platelet functions by P2 receptors.

Authors:  Christian Gachet
Journal:  Annu Rev Pharmacol Toxicol       Date:  2006       Impact factor: 13.820

Review 4.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

5.  Light-directed, spatially addressable parallel chemical synthesis.

Authors:  S P Fodor; J L Read; M C Pirrung; L Stryer; A T Lu; D Solas
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

6.  Regulation of death and survival in astrocytes by ADP activating P2Y1 and P2Y12 receptors.

Authors:  Liaman K Mamedova; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2006-08-28       Impact factor: 5.858

Review 7.  Controlling cell chemistry with caged compounds.

Authors:  S R Adams; R Y Tsien
Journal:  Annu Rev Physiol       Date:  1993       Impact factor: 19.318

8.  Metabotropic P2Y receptors inhibit P2X3 receptor-channels via G protein-dependent facilitation of their desensitization.

Authors:  Z Gerevich; Z Zadori; C Müller; K Wirkner; W Schröder; P Rubini; P Illes
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

9.  Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptor.

Authors:  Marco Cattaneo; Anna Lecchi; Michihiro Ohno; Bhalchandra V Joshi; Pedro Besada; Susanna Tchilibon; Rossana Lombardi; Norbert Bischofberger; T Kendall Harden; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2004-11-15       Impact factor: 5.858

10.  Signaling of the Human P2Y(1) Receptor Measured by a Yeast Growth Assay with Comparisons to Assays of Phospholipase C and Calcium Mobilization in 1321N1 Human Astrocytoma Cells.

Authors:  Ronald T Niebauer; Zhan-Guo Gao; Bo Li; Jürgen Wess; Kenneth A Jacobson
Journal:  Purinergic Signal       Date:  2005-09       Impact factor: 3.765

View more
  6 in total

Review 1.  Medicinal chemistry of adenosine, P2Y and P2X receptors.

Authors:  Kenneth A Jacobson; Christa E Müller
Journal:  Neuropharmacology       Date:  2015-12-12       Impact factor: 5.250

Review 2.  Nucleotides Acting at P2Y Receptors: Connecting Structure and Function.

Authors:  Kenneth A Jacobson; Silvia Paoletta; Vsevolod Katritch; Beili Wu; Zhan-Guo Gao; Qiang Zhao; Raymond C Stevens; Evgeny Kiselev
Journal:  Mol Pharmacol       Date:  2015-04-02       Impact factor: 4.436

3.  Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers.

Authors:  Zhan-Guo Gao; Dennis Verzijl; Annelien Zweemer; Kai Ye; Anikó Göblyös; Adriaan P Ijzerman; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2011-06-21       Impact factor: 5.858

4.  Pharmacochemistry of the platelet purinergic receptors.

Authors:  Kenneth A Jacobson; Francesca Deflorian; Shilpi Mishra; Stefano Costanzi
Journal:  Purinergic Signal       Date:  2011-02-18       Impact factor: 3.765

5.  P2Y(13) receptor is responsible for ADP-mediated degranulation in RBL-2H3 rat mast cells.

Authors:  Zhan-Guo Gao; Yi Ding; Kenneth A Jacobson
Journal:  Pharmacol Res       Date:  2010-09-08       Impact factor: 7.658

Review 6.  Optical control of purinergic signaling.

Authors:  Tao Wang; Henning Ulrich; Alexey Semyanov; Peter Illes; Yong Tang
Journal:  Purinergic Signal       Date:  2021-06-22       Impact factor: 3.765

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.